D.E. Shaw & Co
INSP icon

D.E. Shaw & Co’s Inspire Medical Systems INSP Stock Holding History

D.E. Shaw & Co’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$573K Buy
+11,100
New +$777K ﹤0.01% 3782
2025
Q1 		– Sell
-2,500
Closed -$463K – 4473
2024
Q4 		$463K Sell
2,500
-47,600
-95% -$9.24M ﹤0.01% 3665
2024
Q3 		$10.6M Hold
50,100
– – 0.01% 1396
2024
Q2 		$6.7M Sell
50,100
-10,000
-17% -$1.89M 0.01% 1625
2024
Q1 		$12.9M Sell
60,100
-10,600
-15% -$2.08M 0.01% 1207
2023
Q4 		$14.4M Buy
70,700
+33,900
+92% +$5.49M 0.01% 1131
2023
Q3 		$7.3M Buy
36,800
+7,100
+24% +$1.79M 0.01% 1501
2023
Q2 		$9.64M Buy
29,700
+9,700
+49% +$2.77M 0.01% 1367
2023
Q1 		$4.68M Buy
+20,000
New +$5.06M 0.01% 1990
2022
Q2 		– Sell
-10,000
Closed -$2.57M – 5531
2022
Q1 		$2.57M Hold
10,000
– – ﹤0.01% 3055
2021
Q4 		$2.3M Hold
10,000
– – ﹤0.01% 3225
2021
Q3 		$2.33M Hold
10,000
– – ﹤0.01% 2893
2021
Q2 		$1.93M Buy
+10,000
New +$1.98M ﹤0.01% 2970

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

D.E. Shaw & Co's INSP Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Inspire Medical Systems (INSP) stake by 1.9% in Q1 2026, selling an estimated $1.65M and leaving 1,188,537 shares worth $61.3M. The position accounts for 0.04% of the portfolio, ranked #572.

D.E. Shaw & Co first reported a position in INSP in Q3 2018 and has held it in 31 quarters since. The position peaked at $136M in Q2 2023. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • D.E. Shaw & Co held 1,188,537 shares of Inspire Medical Systems worth $61.3M as of Q1 2026.
  • D.E. Shaw & Co sold 23,625 Inspire Medical Systems shares in Q1 2026, an estimated $1.65M.
  • Inspire Medical Systems made up 0.04% of D.E. Shaw & Co's portfolio in Q1 2026, its #572 holding.
  • D.E. Shaw & Co first reported a position in Inspire Medical Systems in Q3 2018 and has held it in 31 quarters since.
  • D.E. Shaw & Co's Inspire Medical Systems position peaked at $136M in Q2 2023.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.